Oliver Karg

Oliver joined Hg in 2021 and focuses on the software and services space in Germany, Switzerland and Austria, covering the Mercury fund. Oliver has been involved in Hg’s investments in Fonds Finanz and LucaNet. He was also involved in the sale of Medifox to Resmed.

Prior to Hg, Oliver worked at Lazard in Frankfurt, where he advised clients on mergers & acquisitions and capital market transactions.

Oliver is from Germany and holds a B.Sc. in Management & Technology from the Technical University of Munich and a M.Sc. in Finance from ESADE.